Cancer Research UK logo.
SearchDonate
  • Search

A trial of talimogene laherparepvec for advanced melanoma

Overview

Cancer types:

Melanoma

Status:

Closed

Phase:

Phase 2

Details

This trial is open to people with melanoma that can’t be completely removed by surgery or has spread to another part of the body.

The treatment uses a form of the cold sore virus. It has been changed so it isn’t harmful to normal cells, but destroys cancer cells. The virus is changed by altering the genes that tell it how to behave.

Recruitment start: 9 June 2015

Recruitment end: 2 June 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sophie Papa

Supported by

Amgen

Last reviewed: 11 November 2016

CRUK internal database number: 13631

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.